Company Filing History:
Years Active: 2013-2016
Title: Russell Digate: Innovator in Stem Cell Research and Therapeutics
Introduction
Russell Digate is a prominent inventor based in Wilmington, Delaware. He has made significant contributions to the fields of stem cell research and therapeutic development. With a total of two patents to his name, Digate's work focuses on innovative methods that enhance the creation and application of induced pluripotent stem cells (iPSCs) and therapeutic molecules.
Latest Patents
Digate's latest patents include groundbreaking technologies. The first patent, titled "Complexation of fatty acid-conjugated molecules with albumin," describes novel methods for conjugating therapeutic molecules with fatty acids. This technology allows for the complexation of various functional molecules, such as small chemical drugs and peptides, with human serum albumin protein in vitro. The second patent focuses on the creation of iPSCs through a kinetically controlled process using engineered reprogramming factors. This method optimizes the reprogramming of various cell types, including human fibroblasts, and includes techniques for feeder-free derivation of human iPSCs using synthetic messenger RNA.
Career Highlights
Russell Digate is affiliated with the University of the Sciences in Philadelphia, where he conducts research and develops innovative solutions in the field of biotechnology. His work has garnered attention for its potential applications in regenerative medicine and drug delivery systems.
Collaborations
In his research endeavors,